loadpatents
Patent applications and USPTO patent grants for Dedhar; Shoukat.The latest application filed is for "novel sulfonamide compounds for inhibition of metastatic tumor growth".
Patent | Date |
---|---|
Carbonic anhydrase IX-related markers and use thereof Grant 10,195,174 - McDonald , et al. Fe | 2019-02-05 |
Sulfonamide compounds for inhibition of metastatic tumor growth Grant 9,962,398 - Supuran , et al. May 8, 2 | 2018-05-08 |
Novel Sulfonamide Compounds For Inhibition Of Metastatic Tumor Growth App 20170007627 - SUPURAN; Claudiu ;   et al. | 2017-01-12 |
Sulfonamide compounds for inhibition of metastatic tumor growth Grant 9,463,171 - Supuran , et al. October 11, 2 | 2016-10-11 |
Carbonic Anhydrase Ix-related Markers And Use Thereof App 20140303103 - McDonald; Paul C. ;   et al. | 2014-10-09 |
Carbonic Anhydrase Inhibitors With Antimetastatic Activity App 20140148400 - Supuran; Claudiu ;   et al. | 2014-05-29 |
Biomarkers of cancer metastasis Grant 8,735,061 - Lou , et al. May 27, 2 | 2014-05-27 |
Novel Sulfonamide Compounds For Inhibition Of Metastatic Tumor Growth App 20130190396 - Supuran; Claudiu ;   et al. | 2013-07-25 |
Biomarkers Of Cancer Metastasis App 20120301891 - LOU; Yuanmei ;   et al. | 2012-11-29 |
Treatment of inflammatory diseases including psoriasis Grant 7,863,429 - Dedhar , et al. January 4, 2 | 2011-01-04 |
Biomarkers Of Cancer Metastasis App 20100317533 - LOU; Yuanmei ;   et al. | 2010-12-16 |
Integrin-linked kinase and its uses Grant 7,655,780 - Dedhar , et al. February 2, 2 | 2010-02-02 |
Integrin-linked kinase and its uses App 20080039419 - Dedhar; Shoukat ;   et al. | 2008-02-14 |
Integrin-linked kinase and its uses App 20070203326 - Dedhar; Shoukat ;   et al. | 2007-08-30 |
Integrin-linked kinase and its uses Grant 7,189,802 - Dedhar , et al. March 13, 2 | 2007-03-13 |
Antiangiogenic compounds and an assay for inhibitors of cell invasion App 20050222126 - Roskelley, Calvin ;   et al. | 2005-10-06 |
Integrin-linked kinase and its uses App 20040106107 - Dedhar, Shoukat ;   et al. | 2004-06-03 |
Integrin-linked kinase and its uses Grant 6,699,983 - Dedhar , et al. March 2, 2 | 2004-03-02 |
Novel use of calreticulin in modulating hormone responsiveness and new pharmaceuticals for treating cancer, osteoporosis and chronic inflammatory disease App 20030060613 - Dedhar, Shoukat | 2003-03-27 |
Pharmaceuticals for modulating hormone responsiveness Grant 6,518,397 - Dedhar February 11, 2 | 2003-02-11 |
Antiangiogenic compounds and an assay for inhibitors of cell invasion App 20030004149 - Roskelley, Calvin ;   et al. | 2003-01-02 |
Treatment of inflammatory diseases including psoriasis App 20020155179 - Dedhar, Shoukat ;   et al. | 2002-10-24 |
Integrin-linked kinase and its uses App 20020122801 - Dedhar, Shoukat ;   et al. | 2002-09-05 |
Integrin-linked kinase and its use App 20020107216 - Dedhar, Shoukat ;   et al. | 2002-08-08 |
Integrin-linked kinase and its use Grant 6,001,622 - Dedhar , et al. December 14, 1 | 1999-12-14 |
Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same Grant 5,854,202 - Dedhar December 29, 1 | 1998-12-29 |
NCAGE Code | L5693 | DEDHAR, SHOUKAT |
CAGE Code | L5693 | DEDHAR, SHOUKAT |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.